Bloomberg Baystate Business: Depression Meds and Quanterix

Bloomberg Baystate Business
|

Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston. Today: Bloomberg News Washington Correspondent Toluse Olorunnipa on the possibility of a goverrnment shutdown and the latest on tax overhaul. Bloomberg News Reporter Anne Mostue on the surge of Sage Therapeutics and its new depression medication. Melissa Mittelman, Bloomberg News Private Equity Reporter, on Goldman, Blackrock and Blackstone keeping their crowns. Quanterix CEO Kevin Hrusovsky on his company’s IPO and first day of trading, Boston Globe Reporter Tim Logan on the local impact of the tax overhaul. Rei Goffer, Chief Strategy Officer at ClimaCell, on selling weather data. And David Smith, Rockland Trust Chief Investment Officer, talks about the markets.

 

Listen to the entire segment at bloomberg.com

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more